Skip to content

What's happening to benefits?

HIV prevention: does scaring people work?

From Kenya to Kennington

Towards a cure for all (part one)

A winter of discontent?

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

Little evidence of transmission of virus that's resistant to newer anti-HIV drugs

Bone loss a general side-effect of HIV therapy, suggests small study

Treatment interruptions explain higher HIV viral load in patients with depression and those who use stimulants